C. Muzi

Clinical and prognostic role of interim 18F-FDG PET/CT in elderly Hodgkin lymphoma: a dual-center experience

F. Bertagna, D. Albano, R. Giubbini, 2020, Leukemia & lymphoma.

Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in elderly HL: a two-center experience in 123 patients

F. Bertagna, D. Albano, R. Giubbini, 2020, Annals of Hematology.

Safety and efficacy of netupitant/palonosetron and dexamethasone in classical Hodgkin’s lymphoma patients with inadequate chemotherapy-induced nausea and vomiting prophylaxis with palonosetron and dexamethasone: a single-center real-life experience

P. Minga, R. Cairoli, Paolo Codega, 2020, International journal of hematologic oncology.

Ibrutinib improves survival compared to chemotherapy in mantle cell lymphoma with central nervous system relapse.

E. Giné, M. Dreyling, C. Cheah, 2022, Blood.

Current Treatment Options and the Role of Functional Status Assessment in Classical Hodgkin Lymphoma in Older Adults: A Review

R. Cairoli, V. Zilioli, A. Re, 2023, Cancers.

Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience

F. Merli, L. Marcheselli, D. Albano, 2021, Journal of cachexia, sarcopenia and muscle.

Comparison between skeletal muscle and adipose tissue measurements with high-dose CT and low-dose attenuation correction CT of 18F-FDG PET/CT in elderly Hodgkin lymphoma patients: a two-centre validation

M. Ravanelli, D. Farina, F. Bertagna, 2021, The British journal of radiology.